Literature DB >> 19046730

Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire.

F A Klok1, J E Tijmensen, M L A Haeck, K W van Kralingen, M V Huisman.   

Abstract

BACKGROUND: There is a lack of information on long term complications of patients with pulmonary embolism (PE), including chronic complaints of dyspnea.
METHODS: Consecutive patients with a prior diagnosis of acute PE and an age and gender matched control group with no medical history of PE were presented with a questionnaire, designed to establish the presence, severity and possible causes of dyspnea in the clinical course of PE.
RESULTS: The questionnaire was taken in 48 PE-survivors 40+/-7.4 months after PE; 27 patients (56%) had complaints of dyspnea. Sixteen (35%) were categorized as NYHA class II, 6 (13%) as class III and 5 (10%) as class IV. Overall, 19 patients (70%) had new or worsened complaints after PE. The study included 61 controls. Corrected for gender, age and medical history, the control group was significantly less dyspnoeic compared to the PE survivors (p<0.001). Corrected for gender and age, patients were 4 times more often in NYHA class II (OR 3.6 95%CI 1.4-9.7) and 7-fold more often in NYHA class III or IV (OR 6.5 95%CI 1.7-24), both compared to control subjects.
CONCLUSION: A large percentage of patients with prior PE have persistent complaints of dyspnea at long term follow-up. The majority of them developed new or worsened dyspnea after the thrombo-embolic event. In comparison to a control population without a medical history of VTE, PE patients were overall significantly more dyspnoeic. An explanation for this phenomenon needs to be studied in further functional work-up of these patients.

Entities:  

Mesh:

Year:  2008        PMID: 19046730     DOI: 10.1016/j.ejim.2008.02.006

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  14 in total

1.  High Prevalence of Persistent Breathlessness Following Sub-Massive Pulmonary Embolism in Patients Presenting to a Large Regional Hospital in South Wales.

Authors:  Patrick Flood-Page
Journal:  Turk Thorac J       Date:  2020-11-01

2.  Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort.

Authors:  Mazdak Tavoly; Lars-Petter Jelsness-Jørgensen; Hilde Skuterud Wik; Christina Roaldsnes; Per Morten Sandset; Waleed Ghanima
Journal:  Qual Life Res       Date:  2014-08-14       Impact factor: 4.147

Review 3.  Short- and Long-term Mortality Risk After Acute Pulmonary Embolism.

Authors:  Rajesh Gupta; Dylan D Fortman; Daniel R Morgenstern; Christopher J Cooper
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

4.  Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism.

Authors:  Ming Sheng Lim; Dee Nandurkar; Ian Jong; Anita Cummins; Huyen Tran; Sanjeev Chunilal
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300

Review 5.  Application of pulmonary rehabilitation in patients with pulmonary embolism (Review).

Authors:  Aiping Yu; Weiping Ding; Wanmi Lin; Juan Cai; Weina Huang
Journal:  Exp Ther Med       Date:  2021-12-01       Impact factor: 2.447

6.  Health-related quality of life after pulmonary embolism: a cross-sectional study.

Authors:  Mazdak Tavoly; Kristin Kornelia Utne; Lars-Petter Jelsness-Jørgensen; Hilde Skuterud Wik; Frederikus A Klok; Per Morten Sandset; Waleed Ghanima
Journal:  BMJ Open       Date:  2016-11-03       Impact factor: 2.692

7.  How the Results of a Randomized Trial of Catheter-Directed Thrombolysis Versus Anticoagulation alone for Submassive Pulmonary Embolism Would Affect Patient and Physician Decision Making: Report of an Online Survey.

Authors:  Bedros Taslakian; Clayton Li; Samuel Z Goldhaber; Kathryn Z Mikkelsen; James M Horowitz; Christopher Kabrhel; Geoffrey D Barnes; Akhilesh K Sista
Journal:  J Clin Med       Date:  2019-02-07       Impact factor: 4.241

8.  Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries.

Authors:  Ling-Hsiang Chuang; Pearl Gumbs; Ben van Hout; Giancarlo Agnelli; Sonja Kroep; Manuel Monreal; Rupert Bauersachs; Stephen N Willich; Anselm Gitt; Patrick Mismetti; Alexander Cohen; David Jimenez
Journal:  Qual Life Res       Date:  2019-04-04       Impact factor: 4.147

9.  Pulmonary endarterectomy for patients with chronic thromboembolic disease.

Authors:  Şehnaz Olgun Yıldızeli; Alper Kepez; Serpil Taş; Mehmed Yanartaş; Ali Fuad Durusoy; Atakan Erkılınç; Bülent Mutlu; Cihangir Kaymaz; Hasan Sunar; Bedrettin Yıldızeli
Journal:  Anatol J Cardiol       Date:  2018-04       Impact factor: 1.596

10.  Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.

Authors:  Roisin Bavalia; Ingrid M Bistervels; Wim G Boersma; Isabelle Quere; Dominique Brisot; Nicolas Falvo; Dominique Stephan; Francis Couturaud; Sebastian Schellong; Jan Beyer-Westendorf; Karine Montaclair; Waleed Ghanima; Marije Ten Wolde; Michiel Coppens; Emile Ferrari; Olivier Sanchez; Patrick Carroll; Pierre-Marie Roy; Susan R Kahn; Karina Meijer; Simone Birocchi; Michael J Kovacs; Amanda Hugman; Hugo Ten Cate; Hilde Wik; Gilles Pernod; Marie-Antoinette Sevestre-Pietri; Michael A Grosso; Minggao Shi; Yong Lin; Barbara A Hutten; Peter Verhamme; Saskia Middeldorp
Journal:  Res Pract Thromb Haemost       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.